AAAAAA
Results: 1-25/30
Authors:
Kaul, N
Devaraj, S
Jialal, I
Citation: N. Kaul et al., alpha-Tocopherol and Atherosclerosis, EXP BIOL ME, 226(1), 2001, pp. 5-12
Authors:
Yang, TTC
Devaraj, S
Jialal, I
Citation: Ttc. Yang et al., Oxidative stress and atherosclerosis, J CLIN LIG, 24(1), 2001, pp. 13-24
Authors:
Abate, N
Jialal, I
Citation: N. Abate et I. Jialal, Therapy and clinical trials, CURR OP LIP, 12(4), 2001, pp. 471-473
Authors:
Jialal, I
Traber, M
Devaraj, S
Citation: I. Jialal et al., Is there a vitamin E paradox?, CURR OP LIP, 12(1), 2001, pp. 49-53
Authors:
Feldman, M
Jialal, I
Devaraj, S
Cryer, B
Citation: M. Feldman et al., Effects of low-dose aspirin on serum C-reactive protein and thromboxane B-2 concentrations: A placebo-controlled study using a highly sensitive C-reactive protein assay, J AM COL C, 37(8), 2001, pp. 2036-2041
Authors:
O'Byrne, D
Devaraj, S
Islam, KN
Collazo, R
McDonald, L
Grundy, S
Jialal, I
Citation: D. O'Byrne et al., Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy, METABOLISM, 50(2), 2001, pp. 207-215
Authors:
Jialal, I
Devaraj, S
Kaul, N
Citation: I. Jialal et al., The effect of alpha-tocopherol on monocyte proatherogenic activity, J NUTR, 131(2), 2001, pp. 389S-394S
Authors:
Devaraj, S
Hugou, I
Jialal, I
Citation: S. Devaraj et al., alpha-Tocopherol decreases CD36 expression in human monocyte-derived macrophages, J LIPID RES, 42(4), 2001, pp. 521-527
Authors:
Devaraj, S
Hirany, SV
Burk, RF
Jialal, I
Citation: S. Devaraj et al., Divergence between LDL oxidative susceptibility and urinary F-2-isoprostanes as measures of oxidative stress in type 2 diabetes, CLIN CHEM, 47(11), 2001, pp. 1974-1979
Authors:
Jialal, I
Stein, D
Balis, D
Grundy, SM
Adams-Huet, B
Devaraj, S
Citation: I. Jialal et al., Effect of hydroxymethyl glutaryl coenzyme A reductase inhibitor therapy onhigh sensitive C-reactive protein levels, CIRCULATION, 103(15), 2001, pp. 1933-1935
Authors:
Meira, LB
Devaraj, S
Kisby, GE
Burns, DK
Daniel, RL
Hammer, RE
Grundy, S
Jialal, I
Friedberg, EC
Citation: Lb. Meira et al., Heterozygosity for the mouse Apex gene results in phenotypes associated with oxidative stress, CANCER RES, 61(14), 2001, pp. 5552-5557
Authors:
Kaul, N
Devaraj, S
Grundy, SM
Jialal, I
Citation: N. Kaul et al., Failure to demonstrate a major anti-inflammatory effect with alpha tocopherol supplementation (400 IU/day) in normal subjects, AM J CARD, 87(11), 2001, pp. 1320-1323
Authors:
Sharma, N
Rutherford, JD
Grayston, JT
King, LP
Jialal, I
Andrews, TC
Citation: N. Sharma et al., Association between C-reactive protein, anti-Chlamydia pneumoniae antibodies, and vascular function in healthy adults, AM J CARD, 87(1), 2001, pp. 119
Authors:
Devaraj, S
Jialal, I
Citation: S. Devaraj et I. Jialal, Oxidative stress and antioxidants in type 2 diabetes, NUTR HLTH, 2001, pp. 117-125
Authors:
Kroll, MH
Cole, TG
Rifai, N
Cooper, G
Warnick, GR
Jialal, I
Citation: Mh. Kroll et al., Standardization of lipoprotein reporting, AM J CLIN P, 114(5), 2000, pp. 696-702
Authors:
Wu, AHB
Jialal, I
Citation: Ahb. Wu et I. Jialal, How specific is cardiac troponin?, AM J CLIN P, 114(4), 2000, pp. 509-511
Authors:
O'Byrne, D
Grundy, S
Packer, L
Devaraj, S
Baldenius, K
Hoppe, PP
Kraemer, K
Jialal, I
Traber, MG
Citation: D. O'Byrne et al., Studies of LDL oxidation following alpha-, gamma-, or delta-tocotrienyl acetate supplementation of hypercholesterolemic humans, FREE RAD B, 29(9), 2000, pp. 834-845
Authors:
Devaraj, S
Jialal, I
Citation: S. Devaraj et I. Jialal, Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and Type 2 diabetic patients, FREE RAD B, 29(8), 2000, pp. 790-792
Authors:
Traber, MG
Jialal, I
Citation: Mg. Traber et I. Jialal, Measurement of lipid-soluble vitamins - further adjustment needed?, LANCET, 355(9220), 2000, pp. 2013-2014
Authors:
Jialal, I
Devaraj, S
Citation: I. Jialal et S. Devaraj, Vitamin E supplementation and cardiovascular events in high-risk patients., N ENG J MED, 342(25), 2000, pp. 1917-1917
Authors:
Islam, KN
O'Byrne, D
Devaraj, S
Palmer, B
Grundy, SM
Jialal, I
Citation: Kn. Islam et al., Alpha-tocopherol supplementation decreases the oxidative susceptibility ofLDL in renal failure patients on dialysis therapy, ATHEROSCLER, 150(1), 2000, pp. 217-224
Authors:
Hirany, S
O'Byrne, D
Devaraj, S
Jialal, I
Citation: S. Hirany et al., Remnant-like particle-cholesterol concentrations in patients with type 2 diabetes mellitus and end-stage renal disease, CLIN CHEM, 46(5), 2000, pp. 667-672
Authors:
Devaraj, S
Jialal, I
Citation: S. Devaraj et I. Jialal, Low-density lipoprotein postsecretory modification, monocyte function, andcirculating adhesion molecules in type 2 diabetic patients with and without macrovascular complications - The effect of alpha-tocopherol supplementation, CIRCULATION, 102(2), 2000, pp. 191-196
Authors:
Devaraj, S
Hirany, S
Jialal, I
Citation: S. Devaraj et al., Ratio of remnant-like particle cholesterol to serum total triglycerides isa reliable screening test for type III dyslipidaemia, ANN CLIN BI, 37, 2000, pp. 790-791
Authors:
Marangon, K
O'Byrne, D
Devaraj, S
Jialal, I
Citation: K. Marangon et al., Validation of an immunoassay for measurement of plasma total homocysteine, AM J CLIN P, 112(6), 1999, pp. 757-762